GSK
GSK plcWhen GSK passed all Ten ChecksGSK plc
history · not a forecastOver the past 10 years, GSK has passed all Ten Checks on 11 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +14.9% in Sep 2025, peaked day 19.
- Nov 2025+4.8% +0.4%
- Sep 2025+14.9% -0.2%
- Oct 2023+2.5% -6.8%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about GSK’s checks
How many technical checks does GSK pass right now?
As of the Aug 26, 2026 close, GSK passes 3 of 10 fixed technical checks — the checks not passing: market trend rising, holding above short-term average, not overextended, no recent earnings miss, outperforming the market, stop distance within range, adequate stop room.
Why does GSK fail the "holding above short-term average" check?
GSK closed at $51.43, 0.4% below its 9-day average ($51.61), so this momentum check fails. It passes again on a close above $51.61.
What price would change GSK's check count?
The nearest flip level is "holding above short-term average" passes on a close above $51.66. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.